April 18, 2013

Coke Zero has seen double-digit sales growth over the last five years, according to the company, and Coke is hoping to increase those numbers even more this summer with the release of Caffeine Free Coke Zero.

April 18, 2013

Diplomat Specialty Pharmacy has several new programs in the works to promote health and wellness among its employees, the company said.

April 18, 2013

Haagen-Dazs welcomed the newest member to its product family with seven flavors of gelato available nationwide.

April 18, 2013

Generic drug maker Hospira has appointed Matt Stober as its SVP operations, the company said.

April 18, 2013

Mike's Hard Lemonade is expanding its line of product offerings with the addition of several new entries in the beer and cider categories, the company announced this week.

April 18, 2013

Tea of a Kind, a tea beverage company, announced a wide distribution expansion into retail pharmacies, grocery stores and supermarkets in Northern California, Nevada, Arizona, New Mexico and more.

April 17, 2013

On May 6, Budweiser will introduce a new bowtie-shaped aluminum can to hit store shelves.

April 17, 2013

Results of a survey indicate a positive response among patients to redesigned patient medication information distributed to patients at retail pharmacy chains in two states as part of an eight-week program.

April 17, 2013

The Food and Drug Administration has approved a modification to a program added to the labeling of an obesity drug to ensure patient safety.

April 17, 2013

Costco and IRI announced Wednesday that they will change a program that the club retailer describes as a single, global solution for category, point-of-sale and supply chain tracking, as well as extend the program to Mexico.

April 17, 2013

NorthWest Specialty Baking Mixes announced this week the introduction of new branded baking mixes: Dassant Classics.

April 17, 2013

The way women depict themselves is dramatically different from how others perceive them. That’s according to the research findings by Unilever’s Dove brand.

April 17, 2013

Dr Pepper announced “Be the Next /1” — a national consumer contest that offers fans the chance to star in upcoming national TV and digital advertising.

April 17, 2013

A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.

April 17, 2013

Chuck Woolery, TV personality and game show host, has recently acquired a minority stake in Nature’s Health Connection, Inc., the makers of Australian Dream Arthritis Pain Relief Cream.

April 17, 2013

Food and Drug Administration commissioner Margaret Hamburg faced strong criticism Tuesday in a hearing before the House Committee on Energy and Commerce to investigate the nationwide outbreak of fungal meningitis linked to a Massachusetts compounding pharmacy, but she conceded the agency could have done more.

April 17, 2013

Jack Link's announced earlier this month the introduction of a new line of products with packaging and graphics targeted toward the millennial generation.

April 17, 2013

Starting today, April 17, Kleenex brand, the only facial tissue with Sneeze Shield in all of its tissues, according to the company, is giving three schools a chance to win 250,000 eBoxTops for the 2013-2014 school year through the Kleenex brand in the Classroom sweepstakes.

April 17, 2013

L’Oréal USA has named Angela Bennett VP of global skin care brand La Roche-Posay.

April 17, 2013

The family-owned Schupp GmbH and Co. KG company has just developed and launched a new type of kinesiology tape, the German company announced.

April 17, 2013

Generic drug maker Sandoz has launched a generic version of a drug used to treat high blood pressure and angina.

April 17, 2013

Tria Beauty, a maker of light-based skin care products and technology, has inked a new partnership with beauty retailer Ulta.

April 17, 2013

Zak Designs announced the latest product license for its line of dinnerware for kids.

April 16, 2013

Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.